COVID-19 is an emerging pandemic infecting more than 11 million people and leading to
more than 544,722 deaths worldwide at the time of writing this report. Despite the …

The newly identified severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
causes COVID-19, a pandemic respiratory disease. Moreover, thromboembolic events …

Anosmia, the loss of smell, is a common and often the sole symptom of COVID-19. The onset
of the sequence of pathobiological events leading to olfactory dysfunction remains obscure …

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes severe viral
pneumonia and is associated with a high fatality rate. A substantial proportion of patients …

SARS-CoV-2 causes profound changes in the sense of smell, including total smell loss.
Although these alterations are often transient, many patients with COVID-19 exhibit olfactory …

A prominent clinical symptom of 2019-novel coronavirus (nCoV) infection is
hyposmia/anosmia (decrease or loss of sense of smell), along with general symptoms such …

Background: Little is still known about the mid/long-term effects of coronavirus disease 2019
(COVID-19) on the brain, especially in subjects who have never been hospitalized due to …

A comprehensive review of the neurological disorders reported during the current COVID-19
pandemic demonstrates that infection with SARS-CoV-2 affects the central nervous system …

Importance Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in
December 2019, causing human coronavirus disease 2019 (COVID-19), which has now …

SARS-CoV-2 infection of the upper airway and the subsequent immune response are early,
critical factors in COVID-19 pathogenesis. By studying infection of human biopsies in vitro …